Sabo RT - Search Results

1

Optimal and lead-in adaptive allocation for binary outcomes: a comparison of Bayesian methodologies.

Sabo RT, Bello G. Sabo RT, et al. Commun Stat Theory Methods. 2017;46(6):2823-2836. doi: 10.1080/03610926.2015.1053929. Epub 2016 Apr 8. Commun Stat Theory Methods. 2017. PMID: 29081575 Free PMC article.

2

Adaptive allocation for binary outcomes using decreasingly informative priors.

Sabo RT. Sabo RT. J Biopharm Stat. 2014;24(3):569-78. doi: 10.1080/10543406.2014.888441. J Biopharm Stat. 2014. PMID: 24697793

3

Engaging primary care patients to use a patient-centered personal health record.

Krist AH, Woolf SH, Bello GA, Sabo RT, Longo DR, Kashiri P, Etz RS, Loomis J, Rothemich SF, Peele JE, Cohn J. Krist AH, et al. Among authors: sabo rt. Ann Fam Med. 2014 Sep-Oct;12(5):418-26. doi: 10.1370/afm.1691. Ann Fam Med. 2014. PMID: 25354405 Free PMC article.

4

Frequency and prioritization of patient health risks from a structured health risk assessment.

Phillips SM, Glasgow RE, Bello G, Ory MG, Glenn BA, Sheinfeld-Gorin SN, Sabo RT, Heurtin-Roberts S, Johnson SB, Krist AH; MOHR Study Group. Phillips SM, et al. Among authors: sabo rt. Ann Fam Med. 2014 Nov-Dec;12(6):505-13. doi: 10.1370/afm.1717. Ann Fam Med. 2014. PMID: 25384812 Free PMC article.

5

A natural lead-in approach to response-adaptive allocation for continuous outcomes.

Donahue E, Sabo RT. Donahue E, et al. Among authors: sabo rt. Pharm Stat. 2021 May;20(3):563-572. doi: 10.1002/pst.2094. Epub 2021 Jan 22. Pharm Stat. 2021. PMID: 33484036 Free PMC article.

6

What can go wrong when ignoring correlation bounds in the use of generalized estimating equations.

Sabo RT, Chaganty NR. Sabo RT, et al. Stat Med. 2010 Oct 30;29(24):2501-7. doi: 10.1002/sim.4013. Stat Med. 2010. PMID: 20690109

7

Recent innovations in adaptive trial designs: A review of design opportunities in translational research.

Kaizer AM, Belli HM, Ma Z, Nicklawsky AG, Roberts SC, Wild J, Wogu AF, Xiao M, Sabo RT. Kaizer AM, et al. Among authors: sabo rt. J Clin Transl Sci. 2023 Apr 28;7(1):e125. doi: 10.1017/cts.2023.537. eCollection 2023. J Clin Transl Sci. 2023. PMID: 37313381 Free PMC article. Review.

8

Maintenance azacitidine after myeloablative allogeneic hematopoietic cell transplantation for myeloid malignancies.

Maples KT, Sabo RT, McCarty JM, Toor AA, Hawks KG. Maples KT, et al. Among authors: sabo rt. Leuk Lymphoma. 2018 Dec;59(12):2836-2841. doi: 10.1080/10428194.2018.1443334. Epub 2018 Apr 4. Leuk Lymphoma. 2018. PMID: 29616863

9

Early termination in single-parameter model phase II clinical trial designs using decreasingly informative priors.

Wang C, Sabo RT, Mukhopadhyay ND, Perera RA. Wang C, et al. Among authors: sabo rt. Int J Clin Trials. 2022 Apr-Jun;9(2):107-117. doi: 10.18203/2349-3259.ijct20221110. Epub 2022 Apr 25. Int J Clin Trials. 2022. PMID: 36846554 Free PMC article.

10

Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients.

Portier DA, Sabo RT, Roberts CH, Fletcher DS, Meier J, Clark WB, Neale MC, Manjili MH, McCarty JM, Chung HM, Toor AA. Portier DA, et al. Among authors: sabo rt. Bone Marrow Transplant. 2012 Dec;47(12):1513-9. doi: 10.1038/bmt.2012.81. Epub 2012 May 14. Bone Marrow Transplant. 2012. PMID: 22580767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page